RT Journal Article
SR Electronic
T1 Secondary Hyperparathyroidism: Pathophysiology and Treatment
JF The Journal of the American Board of Family Medicine
JO J Am Board Fam Med
FD American Board of Family Medicine
SP 574
OP 581
DO 10.3122/jabfm.2009.05.090026
VO 22
IS 5
A1 Wissam Saliba
A1 Boutros El-Haddad
YR 2009
UL http://www.jabfm.org/content/22/5/574.abstract
AB Secondary hyperparathyroidism is a frequently encountered problem in the management of patients with chronic kidney disease (CKD). Its pathophysiology is mainly due to hyperphosphatemia and vitamin D deficiency and resistance. This condition has a high impact on the mortality and morbidity of dialysis patients. Early diagnosis of secondary hyperparathyroidism is crucial in the management of patients with CKD. The treatment remains a challenge for patients and their clinicians. It should include a combination of dietary phosphorus restriction, phosphate binders, vitamin D analogues, and calcimimetics.